National Vision EYE

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$1.32 (-10.25%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

National Vision (EYE) Business Model and Operations Summary
National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

Key Insights

National Vision (EYE) Core Market Data and Business Metrics
  • Latest Closing Price

    $12.88
  • Market Cap

    $902.86 Million
  • Price-Earnings Ratio

    -35.78
  • Total Outstanding Shares

    78.78 Million Shares
  • Total Employees

    13,411
  • Dividend

    No dividend
  • IPO Date

    October 26, 2017
  • SIC Description

    Ophthalmic Goods
  • Primary Exchange

    NASDAQ
  • Headquarters

    2435 Commerce Avenue, Duluth, GA, 30096-4980

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Short Interest

Short Interest

This information is bi-monthly aggregated short interest data reported to the Financial Industry Regulatory Authority (FINRA) by broker-dealers.

Average Daily Volume: The average number of shares traded per day over the specified period.

Days to Cover: The estimated number of days it would take to cover all short positions based on average trading volume.

Settlement Date: The date on which the short interest data is considered settled, typically based on exchange reporting schedules.

Short Interest: The total number of shares that have been sold short but have not yet been covered or closed out.

Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Short InterestBi-Weekly Change (%)Settlement DateDays to Cover
6,729,155 Shares+22.92%3/14/20254.26
5,474,410 Shares+12.90%2/28/20253.06
4,848,932 Shares-2.33%2/14/20254.06
4,964,379 Shares+15.18%1/31/20253.51
4,310,159 Shares+15.90%1/15/20253.21
3,718,728 Shares+13.38%12/31/20242.98

Cash Flow Statement

December 31, 2023 to December 28, 2024
MetricValue
Net Cash Flow From Investing Activities, Continuing$-96.09 Million
Net Cash Flow From Financing Activities, Continuing$-113.34 Million
Net Cash Flow From Investing Activities$-96.09 Million
Net Cash Flow, Continuing$-75.79 Million
Net Cash Flow From Operating Activities, Continuing$133.65 Million
Net Cash Flow$-75.79 Million

Income Statement

December 31, 2023 to December 28, 2024
MetricValue
Preferred Stock Dividends And Other Adjustments$0
Net Income/Loss Attributable To Noncontrolling Interest$0
Depreciation and Amortization$91.35 Million
Net Income/Loss Available To Common Stockholders, Basic$-28.50 Million
Income/Loss From Continuing Operations After Tax$-27.16 Million
Operating Income/Loss$-10.36 Million

Comprehensive Income

December 31, 2023 to December 28, 2024
MetricValue
Other Comprehensive Income/Loss$-28.08 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Comprehensive Income/Loss$-28.08 Million
Comprehensive Income/Loss Attributable To Parent$-28.08 Million

Balance Sheet

December 31, 2023 to December 28, 2024
MetricValue
Equity$816.33 Million
Noncurrent Liabilities$723.16 Million
Inventory$93.92 Million
Noncurrent Assets$1.76 Billion
Current Assets$249.83 Million
Current Liabilities$468.27 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about EYE from trusted financial sources